Showing results (71-80 of 182) with videos related to
Sort By:
Pageof 19
American Journal of Hematology|March 22, 2019
Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registryRobert N Stuver, Niloufer Khan, Marc Schwartz, et al.Journal of the American Academy of Dermatology|February 1, 2019
Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skinMeenal K Kheterpal, Julia Dai, Shamir Geller, et al.Haematologica|November 27, 2025
Cumulative incidence and factors associated with subsequent myeloid neoplasms in patients with nodal T-follicular helper cell lymphomasKai Shiang Lin, Mingfei Yan, Nivetha Ganesan, et al.Cancer|June 22, 2010
A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic scoreAdrienne A Phillips, Iuliana Shapira, Robert D Willim, et al.American Journal of Hematology|February 18, 2011
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter studyJorge J Castillo, Brady E Beltran, Michele Bibas, et al.CA: a Cancer Journal for Clinicians|June 29, 2026
Extranodal natural killer/T-cell lymphoma: From fatal to curableJie Xiong, Yok-Lam Kwong, Laurence de Leval, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Paul A Hamlin, Miguel-Angel Perales, et al.Blood|March 7, 2018
Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomasMichelle A Fanale, Steven M Horwitz, Andres Forero-Torres, et al.Clinical Lymphoma, Myeloma & Leukemia|June 14, 2020
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort StudyFrederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.Blood Cancer Journal|June 25, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotinShin Yeu Ong, Lu Chen, Jomel Meeko Manzano, et al.Pageof 19